[ill]isseminated Disease due to [ill]ycobacterium chelonei Treated [ill]ith Amikacin and Cefoxitin
- 1 October 1984
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 144 (10) , 2063-2065
- https://doi.org/10.1001/archinte.1984.04400010188033
Abstract
• Disseminated disease due to rapidly growing mycobac[ill]ia is manifested by positive blood cultures and multiple skin [ill]d subcutaneous abscesses. A patient had T-cell lymphoma [ill]d disseminated disease; he also had neutropenla intermit[ill]tly. Single-agent therapy with amikacin sulfate or cefoxitin [ill]dium was not adequate during periods of neutropenia, and [ill]mbination therapy was necessary to control the infection. [ill]nical response correlated with detectable serum inhibitory [ill]els of the antimicrobial agents. Surprisingly, the organism [ill]s not killed by either amikacin or cefoxitin, a finding that [ill]rrelated with the absence of serum bactericidal levels. This [ill]se suggests that granulocytes may play a role in the host's [ill]sponse to this organism, and determination of serum inhib[ill]ry and possible bactericidal levels may be useful in monitor[ill] therapy. (Arch Intern Med 1984;144:2063-2065)This publication has 4 references indexed in Scilit:
- Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilutionAntimicrobial Agents and Chemotherapy, 1982
- Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agentsAntimicrobial Agents and Chemotherapy, 1979
- Disseminated Mycobacterium chelonei infection: response to sulfonamides.Published by Elsevier ,1979
- Mycobacterium chelonei Infection: Successful Treatment Based on a Radiometric Susceptibility TestAntimicrobial Agents and Chemotherapy, 1977